查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553694

REBOA（復甦性主動脈內球囊阻斷）市場規模、佔有率、趨勢分析報告：按應用、地區和細分市場預測，2024-2030 年

Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Size, Share & Trends Analysis Report By End-use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

市場規模及趨勢：

2023年全球REBOA（復甦性主動脈內球囊阻斷）市場規模為958萬美元，預計2024年至2030年複合年成長率為19.9%。

推動該市場發展的是影響臨床實踐成長和採用的幾個關鍵因素。這些促進因素包括創傷性傷害的日益普及、醫療技術的進步、對創傷治療通訊協定的日益重視、醫療保健專業人員意識的提高以及政府的支持性舉措。所有這些因素在塑造市場格局和加強 REBOA 作為救生干預措施的利用方面都發揮著重要作用。

創傷發生率的上升，特別是道路事故、跌倒和暴力造成的創傷，是 REBOA（復甦性主動脈內球囊阻斷）市場的關鍵促進因素。創傷病例常常導致失血性休克，因此對有效復甦技術的需求正在迅速增加。 REBOA 提供了一種微創選項，可以在緊急情況下快速部署，使其成為創傷外科醫生和緊急醫療服務的有吸引力的選擇。 2024 年 6 月，世界衛生組織 (WHO) 報告稱，無意創傷和暴力創傷都是造成創傷的重要原因，每年導致 440 萬人死亡。遭受創傷，尤其是在兒童時期，會增加心理健康問題、藥物濫用、慢性病和社會問題的風險。

醫療設備的技術進步顯著提高了 REBOA 的有效性和安全性。改進的球囊設計、更好的導管系統和改進的成像技術等創新正在促進手術過程中更精確的放置和監測。這些進步不僅改善了患者的治療效果，也鼓勵醫療保健提供者採用 REBOA 作為創傷治療的標準技術。 2024 年 6 月，總部位於猶他州的 Emergency Scientific 宣佈在獲得 FDA 510(k) 批准後首次使用其 Landmark REBOA 導管。此導管用於緊急出血處理時暫時閉塞大血管。標誌性導管旨在提高閉塞精度，同時最大限度地減少與傳統方法相關的併發症。

醫療保健專業人員越來越認知到 REBOA 在治療創傷性出血方面的益處。認知到這一點，我們正在製定專門的培訓計劃，以教育臨床醫生正確使用 REBOA。對教育的日益重視意味著更多的醫療保健提供者擁有有效執行這項挽救生命的程序所需的知識和技能。 2024 年 3 月，《急診醫學雜誌》發表了針對急診醫學 Ta 設計的新型 REBOA 培訓課程的先驅性研究的詳細資訊。這門最先進的課程旨在提高急診部住院醫師應用 REBOA 程序的能力和理解，並改善危及生命的情況下患者的治療結果。

圍繞醫療設備的法規環境越來越支持 REBOA 等創新解決方案。監管機構已經認知到快速介入技術在創傷護理中的重要性，並正在簡化新設備的核准流程。這種支持態度將鼓勵製造商投資研發，進一步推動市場成長。 2024年2月，Neurescue宣佈在A輪資金籌措中籌集了727萬美元。這項投資由倫敦投資公司 West Hill Capital主導。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 REBOA（復甦性主動脈內球囊阻斷）市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場推動要素分析
    • 市場限制因素分析
  • REBOA（復甦性主動脈內球囊阻斷）市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 REBOA（復甦性主動脈內球囊阻斷）市場：最終用途估計與趨勢分析

  • 全球 REBOA（復甦性主動脈內球囊阻斷）市場：最終用途儀表板
  • 全球REBOA（復甦性主動脈內球囊阻斷）市場：最終用途變化分析
  • 按最終用途分類的收益
  • 心臟麻痹
  • 主動脈閉塞
  • 戰術性戰鬥傷患護理

第5章 REBOA（復甦性主動脈內球囊阻斷）市場：按應用、類型和最終用途的區域估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區

第6章 競爭狀況

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 主要客戶
    • 2023年主要企業市場佔有率分析
    • Prytime Medical Devices, Inc
    • NEURESCUE
    • Emergency Scientific, LLC
    • Qx Medical
    • Front Line Medical Technologies
    • Reboa Medical As
Product Code: GVR-4-68040-433-0

Market Size & Trends:

The global resuscitative endovascular balloon occlusion of the aorta market size was valued at USD 9.58 million in 2023 and is projected to grow at a CAGR of 19.9% from 2024 to 2030. The market is driven by several key factors that influence its growth and adoption in clinical settings. These drivers include the increasing prevalence of traumatic injuries, advancements in medical technology, a growing emphasis on trauma care protocols, rising awareness among healthcare professionals, and supportive government initiatives. Each of these elements plays a crucial role in shaping the market landscape and enhancing the utilization of REBOA as a life-saving intervention.

The rising incidence of traumatic injuries, particularly those resulting from road accidents, falls, and violence, is a significant driver for the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) market. As trauma cases often lead to hemorrhagic shock, the demand for effective resuscitation techniques has surged. REBOA provides a minimally invasive option that can be rapidly deployed in emergency situations, making it an attractive choice for trauma surgeons and emergency medical services. In June 2024, the World Health Organization reported that injuries, both unintentional and violence-related, significantly contribute to trauma, leading to 4.4 million deaths annually. Exposure to trauma, especially during childhood, can heighten the risk of mental health issues, substance abuse, chronic diseases, and social problems.

Technological advancements in medical devices have significantly enhanced the efficacy and safety of REBOA procedures. Innovations such as improved balloon designs, better catheter systems, and enhanced imaging technologies facilitate more precise placement and monitoring during procedures. These advancements not only improve patient outcomes but also encourage healthcare providers to adopt REBOA as a standard practice in trauma care. In June 2024, Emergency Scientific, a Utah-based firm, announced the first use of its Landmark REBOA catheter, following its FDA 510(k) clearance. This device is for temporary occlusion of large vessels in emergency hemorrhage control. The Landmark catheter is designed to enhance the precision of occlusion while minimizing complications associated with traditional methods.

There is an increasing awareness among healthcare professionals regarding the benefits of REBOA in managing traumatic hemorrhage. Alongside this awareness, specialized training programs are being developed to educate clinicians on the proper use of REBOA techniques. This growing emphasis on education ensures that more healthcare providers are equipped with the knowledge and skills necessary to implement this life-saving procedure effectively. In March 2024, an article was published in the Journal of Emergency Medicine detailing A Pilot Study on A Novel REBOA Training Curriculum designed for Emergency Medicine Residents. This cutting-edge curriculum was designed to advance the competencies and understanding of Emergency Medicine residents in applying the REBOA technique, with the aim of bettering patient outcomes in life-threatening scenarios.

The regulatory environment surrounding medical devices has become increasingly supportive of innovative solutions like REBOA. Regulatory bodies are recognizing the importance of rapid intervention techniques in trauma care and are streamlining approval processes for new devices. This supportive stance encourages manufacturers to invest in research and development, further propelling market growth. In February 2024, Neurescue announced that it raised USD 7.27 million in a Series A funding round. This investment was spearheaded by West Hill Capital, a London-based investment firm.

Global Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global resuscitative endovascular balloon occlusion of the aorta market report based on end-use, and region:

  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Cardiac Arrest
  • Aortic Occlusion
  • Tactical Combat Casualty Care
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • Japan

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. End Use
    • 1.2.2. Regional scope
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. End Use outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of trauma cases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing awareness and training programs
      • 3.2.1.4. Military applications
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Cost considerations
      • 3.2.2.2. Regulatory challenges
  • 3.3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Estimates & Trend Analysis

  • 4.1. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Dashboard
  • 4.2. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Movement Analysis
  • 4.3. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Estimates and Forecasts, by End Use, Revenue (USD Million)
  • 4.4. Cardiac Arrest
    • 4.4.1. Cardiac arrest market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Aortic Occlusion
    • 4.5.1. Aortic occlusion market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Tactical Combat Casualty Care
    • 4.6.1. Tactical combat casualty care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: Regional Estimates & Trend Analysis by Application, Type, and End Use

  • 5.1. Regional Dashboard
  • 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.3. North America
    • 5.3.1. U.S.
      • 5.3.1.1. Key country dynamics
      • 5.3.1.2. Regulatory framework/ reimbursement structure
      • 5.3.1.3. Competitive scenario
      • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.3.2. Canada
      • 5.3.2.1. Key country dynamics
      • 5.3.2.2. Regulatory framework/ reimbursement structure
      • 5.3.2.3. Competitive scenario
      • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. France
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Key country dynamics
      • 5.4.4.2. Regulatory framework/ reimbursement structure
      • 5.4.4.3. Competitive scenario
      • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Key country dynamics
      • 5.4.5.2. Regulatory framework/ reimbursement structure
      • 5.4.5.3. Competitive scenario
      • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. China
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company/Competition Categorization
  • 6.2. Vendor Landscape
    • 6.2.1. List of key distributors and channel partners
    • 6.2.2. Key customers
    • 6.2.3. Key company market share analysis, 2023
    • 6.2.4. Prytime Medical Devices, Inc
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. NEURESCUE
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Emergency Scientific, LLC
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Qx Medical
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Front Line Medical Technologies
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives
    • 6.2.9. Reboa Medical As
      • 6.2.9.1. Company overview
      • 6.2.9.2. Financial performance
      • 6.2.9.3. Product benchmarking
      • 6.2.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 4 U.S. resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Canada resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 6 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 8 Germany resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 9 UK resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 10 France resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Italy resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Spain resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Asia Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
  • Table 14 Aisa Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 15 China resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Japan resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: market outlook
  • Fig. 9 Resuscitative endovascular balloon occlusion of the aorta (REBOA) competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market driver impact
  • Fig. 13 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market restraint impact
  • Fig. 14 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use movement analysis
  • Fig. 15 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use outlook and key takeaways
  • Fig. 16 Cardiac arrest market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Aortic occlusion market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Tactical combat casualty care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional movement analysis
  • Fig. 20 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional outlook and key takeaways
  • Fig. 21 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market share and leading players
  • Fig. 22 North America, by country
  • Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. key country dynamics
  • Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Canada key country dynamics
  • Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK key country dynamics
  • Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Germany key country dynamics
  • Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 France key country dynamics
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy key country dynamics
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain key country dynamics
  • Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 China key country dynamics
  • Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Japan key country dynamics
  • Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)